No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
667 |
4. Check minimum number of eventsNone |
667 |
5. Include endpointsNone |
667 |
6. Filter based on genotype QC (FinnGen only) |
667 |
Control definitions (FinnGen only)
- Control exclude
- M13_DORSOPATHY
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M43
- Name in latin
- Torticollis
Similar endpoints
↥List of similar endpoints to
Torticollis
based on the number of shared cases.
Similar with more cases:
- Deforming dorsopathies
- Dorsopathies
- Diseases of the musculoskeletal system and connective tissue
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 9116 | 4207 | 4879 |
| Only index persons | 7518 | 3531 | 3987 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.13 | 0.12 | 0.14 |
| Only index persons | 0.14 | 0.13 | 0.15 |
| Median age at first event (years) | |||
| Whole population | 10.56 | 12.33 | 8.83 |
| Only index persons | 12.61 | 14.72 | 10.74 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 667 | 392 | 275 |
| Unadjusted period prevalence (%) | 0.13 | 0.13 | 0.12 |
| Median age at first event (years) | 24.38 | 25.78 | 22.38 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 608
- Matched controls
- 6078
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M43.6
ICD-10 Finland
Torticollis
844.0
323.0
382
12
71720
ICD-8 Finland
Other nonarticular rheumatism, Torticollis not specified as congential, pyschogenic or traumatic
+∞
183.9
167
*
7235A
ICD-9 Finland
Other disorders of cervical region, Torticollis, unspecified
+∞
72.4
68
*
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
22.9
44.1
64
31
N03AX16
ATC
pregabalin; oral
4.7
38.4
148
391
G24.3
ICD-10 Finland
Spasmodic torticollis
53.8
38.1
45
9
M03BX02
ATC
tizanidine; oral
2.9
33.0
395
2393
M03BC01
ATC
orphenadrine (citrate); systemic
3.6
32.2
172
601
N03AX12
ATC
gabapentin; oral
5.5
30.3
95
197
N02AX02
ATC
tramadol; systemic, rectal
2.9
28.7
233
1079
M54.5
ICD-10 Finland
Low back pain
3.0
26.3
182
753
N03AE01
ATC
clonazepam; systemic
6.9
25.7
66
105
M48.0
ICD-10 Finland
Spinal stenosis
26.4
25.5
35
14
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
26.7
24.2
33
13
M54.9
ICD-10 Finland
Dorsalgia, unspecified
5.5
22.7
70
141
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
20.3
21.0
31
16
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
8.1
19.5
44
58
M54.2
ICD-10 Finland
Cervicalgia
6.4
19.4
52
88
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
11.2
19.2
36
34
M54.4
ICD-10 Finland
Lumbago with sciatica
4.1
18.8
76
203
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
5.0
17.9
59
128
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
29.8
17.5
23
8
M01AE02
ATC
naproxen; oral, rectal
2.1
16.9
358
2479
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
10.2
16.9
33
34
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
13.7
14.8
25
19
N06AA09
ATC
amitriptyline; systemic
4.5
14.6
52
123
R51.80
ICD-10 Finland
Headache
2.6
13.6
106
454
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.0
13.5
241
1511
M53.1
ICD-10 Finland
Cervicobrachial syndrome
3.5
13.5
64
196
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
143.0
13.5
14
*
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
143.0
13.5
14
*
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.5
13.1
113
510
M47.82
ICD-10 Finland
Other spondylosis, cervical region
51.1
12.9
15
*
N06AX21
ATC
duloxetine; oral
3.3
12.9
66
215
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
24.9
12.5
17
7
L01
ICPC
Neck symptom/complaint
2.7
12.0
87
356
N02AJ06
ATC
codeine and paracetamol; systemic
2.0
11.6
198
1204
M54.3
ICD-10 Finland
Sciatica
6.6
11.5
29
46
L03
ICPC
Low back symptom/complaint
2.3
11.5
123
614
A02BC02
ATC
pantoprazole; systemic
1.8
11.4
323
2341
H02AB06
ATC
prednisolone; systemic
1.9
11.4
239
1566
M25.5
ICD-10 Finland
Pain in joint
2.1
11.4
153
847
A02BC01
ATC
omeprazole; systemic
2.1
11.2
141
760
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
11.0
207
1299
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
11.0
138
742
ABC16
NOMESCO Finland
Microsurgical excision of lumbar intervertebral disc displacement
61.1
10.7
12
*
M79.6
ICD-10 Finland
Pain in limb
1.9
10.5
176
1060
M50.3
ICD-10 Finland
Other cervical disc degeneration
33.1
10.4
13
*
R03AC02
ATC
salbutamol; inhalant
1.8
10.3
303
2192
M01AB05
ATC
diclofenac; systemic, rectal
1.8
10.3
349
2636
R07.4
ICD-10 Finland
Chest pain, unspecified
2.1
10.2
123
649
M01AH05
ATC
etoricoxib; oral
1.8
10.1
296
2135
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.4
10.0
48
149
N05BA01
ATC
diazepam; systemic, rectal
2.6
10.0
78
330
J45.9
ICD-10 Finland
Asthma, unspecified
2.3
9.6
94
451
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
15.3
9.6
15
10
M47.9
ICD-10 Finland
Spondylosis, unspecified
22.1
9.4
13
6
S80.0
ICD-10 Finland
Contusion of knee
3.2
9.0
47
156
M03BC51
ATC
orphenadrine, combinations; systemic
1.9
9.0
146
861
N02BE01
ATC
paracetamol; systemic, rectal
1.8
9.0
458
3840
M01AC06
ATC
meloxicam; systemic, rectal
1.9
9.0
163
1001
M01AE03
ATC
ketoprofen; systemic, rectal
1.8
8.8
178
1128
M79.1
ICD-10 Finland
Myalgia
2.5
8.7
71
310
R52.1
ICD-10 Finland
Chronic intractable pain
50.7
8.7
10
*
NF1AA
NOMESCO Finland
Hip X-ray examination
3.6
8.6
38
112
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
27.9
8.5
11
*
R07.3
ICD-10 Finland
Other chest pain
2.9
8.4
52
193
ABC26
NOMESCO Finland
Open discectomy of lumbar spine
+∞
8.3
8
*
7227C
ICD-9 Finland
Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]
+∞
8.3
8
*
N06AB04
ATC
citalopram; systemic
2.0
8.3
111
605
C07AA05
ATC
propranolol; systemic
2.0
8.2
114
630
G44.2
ICD-10 Finland
Tension-type headache
2.3
8.2
76
355
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
3.7
8.2
34
95
J01DA01
ATC
[U] cefalexin; systemic
1.6
8.2
338
2631
R52.2
ICD-10 Finland
Other chronic pain
7.0
8.1
19
28
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.5
8.1
36
107
A02BC05
ATC
esomeprazole; systemic
1.7
8.0
183
1203
R52.9
ICD-10 Finland
Pain, unspecified
2.9
7.9
47
171
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
8.6
7.8
16
19
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
45.6
7.7
9
*
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
7.7
109
609
M54.1
ICD-10 Finland
Radiculopathy
9.0
7.6
15
17
N06AX11
ATC
mirtazapine; oral
1.8
7.6
159
1017
L14
ICPC
Leg/thigh symptom/complaint
3.1
7.5
39
131
3338X
ICD-9 Finland
Other extrapyramidal disease and abnormal movement disorders, Fragments of torsion dystonia
81.0
7.4
8
*
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
81.0
7.4
8
*
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
13.6
7.4
12
9
UJF32
NOMESCO Finland
Coloscopy
1.9
7.4
108
608
AA1AD
NOMESCO Finland
CT of head and brain
2.0
7.4
99
540
N06AX16
ATC
venlafaxine; oral
2.2
7.2
78
389
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
7.2
193
1322
XA402
NOMESCO Finland
ENMG
6.7
7.2
17
26
3AX01
NOMESCO Finland
NA
20.3
7.1
10
5
N05CF01
ATC
zopiclone; oral
1.8
7.1
139
866
M79.0
ICD-10 Finland
Rheumatism, unspecified
6.1
7.1
18
30
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
7.0
100
556
N02AA05
ATC
oxycodone; systemic
2.5
7.0
52
217
J01FF01
ATC
clindamycin; systemic
1.8
6.8
139
874
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.8
6.8
43
161
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.8
6.8
131
812
N05AH04
ATC
quetiapine; oral
1.9
6.7
99
560
R03BA05
ATC
fluticasone; inhalant
1.9
6.6
106
618
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.2
6.6
69
340
M53.0
ICD-10 Finland
Cervicocranial syndrome
2.7
6.5
42
161
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.1
6.4
71
359
M45
ICD-10 Finland
Ankylosing spondylitis
70.6
6.4
7
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
6.4
131
823
G43.9
ICD-10 Finland
Migraine, unspecified
2.6
6.4
45
183
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
6.3
234
1735
M53.2
ICD-10 Finland
Spinal instabilities
+∞
6.3
6
*
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
+∞
6.3
6
*
D07AD01
ATC
clobetasol; topical
2.1
6.2
71
361
SPAT1229
SPAT
Assessment of need for aid
3.0
6.2
33
113
N02AC04
ATC
dextropropoxyphene; oral
6.4
6.2
15
24
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
3.4
6.1
27
81
A01
ICPC
Pain general/multiple sites
2.7
6.1
39
148
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
10.2
6.0
11
11
G43.3
ICD-10 Finland
Complicated migraine
6.1
6.0
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3024561) Albumin [Mass/volume] in Serum or Plasma
258
1769
1.75
10.53
4.2
4.8
g/l
37.0
36.6
0.57
232
1658
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
222
1459
1.78
10.49
3.4
3.0
ng/l
17.3
71.0
1.17
130
839
(3011397) Hemoglobin [Presence] in Urine by Test strip
167
1009
1.87
10.38
3.9
3.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
118
640
2.03
10.05
1.9
1.8
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
348
2617
1.69
9.95
5.7
4.5
mmol/l
6.6
6.6
0.02
337
2381
(3019198) Lymphocytes [#/volume] in Blood
342
2571
1.68
9.71
7.5
5.5
e9/l
2.1
2.0
0.85
311
2289
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
287
2062
1.69
9.67
7.3
6.8
mmol/l
1.2
1.2
0.40
250
1764
(3013115) Eosinophils [#/volume] in Blood
342
2574
1.67
9.64
7.8
5.9
e9/l
0.2
0.2
0.42
309
2281
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
307
2247
1.68
9.63
5.8
6.2
umol/l
10.1
11.7
2.12
293
2137
(40761535) Cells panel - Urine sediment
64
275
2.47
9.59
4.4
3.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
233
1594
1.71
9.35
1.9
1.7
pmol/l
93.7
97.0
0.45
128
849
(3001604) Monocytes [#/volume] in Blood
330
2479
1.66
9.23
7.5
5.5
e9/l
0.6
0.6
0.70
292
2156
(3006315) Basophils [#/volume] in Blood
330
2487
1.65
9.06
7.6
5.6
e9/l
0.0
0.0
0.04
290
2171
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
436
3540
1.67
8.80
7.7
6.7
u/l
79.0
78.1
0.15
427
3328
(3013707) Erythrocyte sedimentation rate by Westergren method
431
3494
1.66
8.70
4.5
3.4
mm/h
10.4
9.9
0.34
411
3232
(3013650) Neutrophils [#/volume] in Blood by Automated count
368
2870
1.63
8.66
10.2
8.8
e9/l
4.1
3.9
0.51
320
2493
(3019150) Specific gravity of Urine by Refractometry
159
1001
1.77
8.45
4.0
3.2
kg/l
1.0
1.0
0.54
23
144
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
82
419
2.09
8.15
1.8
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
122
716
1.86
8.14
1.2
1.2
u/ml
9.2
10.5
0.08
56
289
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
256
1851
1.62
8.02
7.7
6.1
mmol/l
1.2
1.2
1.12
232
1711
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
217
1508
1.65
7.96
4.0
2.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
221
1543
1.65
7.96
10.3
6.8
inr
1.3
1.2
1.11
63
512
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
116
676
1.87
7.90
3.1
2.5
e6/l
0.9
1.3
0.93
71
367
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
82
425
2.06
7.84
1.8
1.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
309
2356
1.58
7.65
3.7
3.0
estimate
0.0
0.0
0.00
56
461
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
262
1923
1.60
7.63
2.3
2.3
nmol/l
73.5
73.4
0.03
242
1774
(3022217) INR in Platelet poor plasma by Coagulation assay
78
401
2.07
7.62
29.0
16.4
inr
1.8
1.2
1.80
13
61
(42870588) Differential panel, method unspecified - Blood
225
1593
1.62
7.60
6.9
5.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
316
2428
1.57
7.53
6.8
5.5
%
56.3
56.0
0.14
294
2305
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
191
1305
1.65
7.40
2.5
2.4
u/l
51.7
55.0
1.20
183
1216
(3023368) Bacteria identified in Blood by Culture
156
1011
1.71
7.39
4.0
4.0
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
318
2469
1.55
7.10
7.0
5.6
%
29.6
29.5
0.03
297
2331
(3026493) Urate [Moles/volume] in Serum or Plasma
162
1076
1.67
6.96
2.0
2.4
umol/l
9510.9
4654.5
0.50
137
978
(3019069) Monocytes/100 leukocytes in Blood
306
2368
1.54
6.86
7.2
5.8
%
8.2
8.4
0.75
286
2242
(3006504) Eosinophils/100 leukocytes in Blood
305
2359
1.54
6.85
7.0
5.6
%
2.7
2.8
0.32
282
2218
(3000850) Epithelial cells [#/volume] in Urine
134
853
1.71
6.72
2.6
2.4
e6/l
7.2
7.8
0.12
117
740
(3019309) Folate [Moles/volume] in Red Blood Cells
105
625
1.81
6.64
1.7
1.7
nmol/l
1135.6
1117.9
0.06
83
475
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
123
767
1.74
6.64
1.2
1.2
iu/ml
36.3
27.7
0.18
32
244
(3022096) Basophils/100 leukocytes in Blood
295
2278
1.53
6.60
7.1
5.7
%
0.7
0.7
0.53
275
2143
(3009261) Glucose [Presence] in Urine by Test strip
306
2386
1.52
6.52
4.0
3.1
estimate
0.0
0.0
0.50
53
452
(3030467) Casts [#/volume] in Urine by Automated count
170
1163
1.62
6.44
3.6
2.8
e6/l
0.3
0.4
0.52
130
845
(3021601) Nitrite [Presence] in Urine by Test strip
303
2370
1.51
6.29
5.3
4.3
estimate
0.0
0.0
0.50
59
478
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
579
5241
1.79
6.14
15.5
10.4
mg/l
20.8
22.2
0.51
481
3943
(3000570) Elastase.pancreatic [Mass/mass] in Stool
31
117
2.73
6.07
1.7
1.4
ug/g
387.9
298.3
1.38
20
65
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
285
2213
1.50
6.06
4.5
3.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
139
920
1.65
5.97
3.0
3.2
ng/l
1329.8
1177.2
0.12
112
764
(3018095) Leukocytes [#/volume] in Urine
217
1595
1.53
5.96
3.8
3.2
e6/l
93.4
125.8
0.30
150
1042
(3037467) Urinalysis macro (dipstick) panel - Urine
398
3318
1.49
5.90
4.5
3.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
70
387
1.90
5.58
6.2
4.3
mmol/l
1.5
1.7
0.13
58
299
(3002582) Erythrocytes [#/volume] in Urine
181
1297
1.54
5.52
3.4
2.8
e6/l
363.3
111.8
0.38
139
965
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
35
148
2.44
5.48
2.0
1.6
g/l
0.2
0.2
0.64
30
139
(36304419) Bacteria [Presence] in Urine
164
1155
1.56
5.40
3.6
2.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
134
904
1.60
5.29
1.6
1.4
nmol/l
21.6
20.3
0.41
116
777
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
46
223
2.14
5.27
1.8
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
169
1209
1.53
5.16
3.5
2.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
197
1461
1.49
5.06
2.9
2.0
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
35
155
2.33
4.98
2.0
1.5
g/l
1.2
1.2
0.06
30
146
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
155
1101
1.53
4.86
2.3
2.0
mg/l
2.6
2.9
0.70
132
941
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
154
1097
1.53
4.76
3.0
2.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
106
693
1.63
4.74
3.1
2.5
ug/g
203.5
118.2
0.68
88
539
(3037522) Nuclear Ab [Titer] in Serum
102
662
1.64
4.69
1.4
1.4
titre
364.6
445.3
0.32
26
137
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
112
747
1.60
4.61
4.2
3.0
ng/l
468.9
613.3
0.18
73
498
(3009508) Creatinine [Moles/volume] in Urine
185
1380
1.47
4.55
2.8
3.4
mmol/l
7.9
8.3
0.48
159
1201
(3016879) Cocaine [Presence] in Urine
63
362
1.82
4.48
2.0
2.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
563
5160
1.58
4.46
16.3
11.6
mmol/l
139.7
139.6
0.37
553
5009
(3029937) Albumin [Presence] in Urine by Test strip
168
1237
1.48
4.39
4.2
3.2
estimate
0.0
0.0
0.31
55
472
(3000764) Benzodiazepines [Presence] in Urine
66
389
1.77
4.32
2.1
2.1
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
65
383
1.77
4.26
8.4
9.2
kpa
5.2
5.1
0.33
60
372
(3027801) Oxygen [Partial pressure] in Arterial blood
65
383
1.77
4.26
8.4
9.2
kpa
12.5
13.0
0.36
60
372
(3016018) Differential panel - Cerebral spinal fluid
15
46
3.31
4.21
1.3
1.5
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
563
5178
1.56
4.19
16.5
11.7
mmol/l
4.0
3.9
0.64
552
5013
(3027008) Opiates [Presence] in Urine
66
393
1.75
4.17
1.7
2.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
451
3979
1.41
4.14
4.3
3.7
pmol/l
14.5
14.5
0.09
414
3667
(3018418) pH of Serum or Plasma
164
1216
1.46
4.11
4.8
3.7
ph
7.4
7.4
0.08
21
238
(3028300) Cannabinoids [Presence] in Urine
66
395
1.74
4.10
2.1
2.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
24
98
2.50
4.09
1.2
1.4
mmol/l
3.8
3.7
0.15
24
92
(40768443) Skin Pathology biopsy report
35
169
2.13
4.09
1.3
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
23
92
2.55
4.09
1.7
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
234
1856
1.40
4.04
4.1
3.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
65
390
1.74
4.01
2.1
2.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
138
994
1.49
4.00
1.9
1.8
mg/l
0.7
1.0
1.29
95
737
(3021589) Normoblasts [#/volume] in Blood
282
2313
1.38
3.97
9.0
8.2
e9/l
0.0
0.0
0.63
237
1884
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
179
1359
1.43
3.94
1.7
1.6
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
97
652
1.57
3.86
2.5
2.3
umol/l
13.1
13.9
0.39
84
602
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
29
133
2.23
3.85
1.6
1.9
ug/l
0.5
4.0
0.96
21
121
(3026782) Osmolality of Urine
119
840
1.51
3.79
2.8
2.5
mosm/kgh2o
552.2
566.2
0.23
99
712
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
213
1678
1.40
3.78
2.9
3.3
u/l
32.4
31.5
0.14
207
1608
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
96
649
1.56
3.72
3.3
2.7
e6/l
4.2
3.8
0.14
50
338
(3011288) Drugs identified in Urine by Screen method
50
285
1.82
3.68
2.1
2.9
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
40
212
1.94
3.67
5.7
8.4
mmol/l
24.6
24.6
0.02
34
200
(3019225) pH of Specimen
61
371
1.71
3.60
2.7
4.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
521
4759
1.43
3.60
5.1
4.3
mu/l
6.3
2.1
0.45
487
4418
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
92
2.44
3.59
1.4
1.1
—
—
—
0
0
(4010399)
50
288
1.80
3.56
1.6
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
63
388
1.69
3.56
8.5
9.2
mmol/l
1.0
1.0
0.01
46
313
(3028707) Methadone [Presence] in Urine by Screen method
34
172
2.03
3.55
1.6
2.7
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
42
229
1.89
3.55
7.2
4.7
mmol/l
24.0
23.7
0.30
33
219
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
10
26
3.89
3.53
1.1
3.3
umol/l
23.7
25.7
—
10
26
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
6
10.07
3.50
1.5
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
51
298
1.77
3.47
2.1
2.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
68
431
1.64
3.45
6.8
5.7
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
7
10
7.06
3.37
3.7
8.9
—
—
—
0
0
(40758558) Short blood count panel - Blood
161
1232
1.40
3.34
7.3
6.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
37
198
1.92
3.32
4.1
6.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
182
1429
1.38
3.23
2.7
3.2
mmol/l
2.4
2.4
0.30
157
1288
(3008898) HLA-B27 [Presence]
36
193
1.91
3.22
1.1
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
24
112
2.19
3.10
1.3
1.4
mg/l
569.1
472.6
0.28
24
107
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
466
4229
1.34
2.97
3.6
3.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
57
360
1.64
2.95
11.4
8.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
32
170
1.93
2.95
1.6
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
47
283
1.71
2.91
1.3
1.2
—
38.6
—
0
14
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
65
427
1.58
2.88
2.7
2.1
u/l
31.5
39.2
0.33
57
363
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
114
842
1.43
2.87
1.6
1.6
pmol/l
425.2
26207320.4
1.02
99
725
(4034850)
28
144
1.99
2.84
8.0
5.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
20
90
2.26
2.82
1.5
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
166
1311
1.35
2.81
1.5
1.4
u/ml
2.8
1.7
0.28
47
342
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
45
272
1.70
2.76
1.7
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
520
4817
1.36
2.76
12.5
9.5
ml/min/173m2
92.2
89.7
1.74
442
3859
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
30
160
1.92
2.75
1.3
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
96
693
1.45
2.74
2.9
2.6
mmol/l
2.4
2.4
0.06
78
617
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
14
5.04
2.73
1.1
1.0
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
28
148
1.93
2.64
1.7
1.6
iu/ml
0.2
0.0
—
7
24
(36660697) Celiac disease serology panel - Serum
69
471
1.52
2.60
1.3
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
153
1207
1.35
2.59
5.3
4.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
32
181
1.81
2.48
1.8
2.0
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
84
605
1.44
2.43
2.6
2.2
g/l
2.5
2.4
0.64
75
561
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
11
40
2.78
2.38
1.2
1.1
mg/l
280.0
231.9
0.21
11
35
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
77
549
1.46
2.36
2.8
2.3
%
24.3
23.6
0.13
63
484
(3044889) 12 lead EKG panel
360
3210
1.26
2.35
3.5
3.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
28
3.24
2.31
2.7
4.8
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
11
41
2.71
2.28
1.4
1.1
mg/l
41.8
43.0
0.03
11
30
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
13
4.65
2.27
1.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
7
18
3.92
2.25
1.1
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
28
157
1.82
2.25
1.1
1.1
u/ml
3.5
8.9
—
8
23
(3007461) Platelets [#/volume] in Blood
632
6110
1.65
2.25
22.3
15.4
e9/l
264.2
254.9
3.13
621
5941
(3000330) Specific gravity of Urine by Test strip
33
195
1.73
2.23
3.6
3.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
14
60
2.36
2.23
3.3
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
82
599
1.42
2.21
2.0
2.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
70
497
1.46
2.20
1.5
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
75
541
1.44
2.17
1.8
1.5
—
—
—
0
0
(3024731) MCV [Entitic volume]
632
6115
1.64
2.17
22.2
15.4
fl
90.0
89.9
0.14
627
6035
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
403
3661
1.25
2.16
3.2
2.9
u/l
44.3
41.4
0.33
386
3485
(3022621) pH of Urine by Test strip
43
276
1.60
2.14
3.5
2.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
139
1111
1.32
2.14
3.0
3.4
mg/l
1620.8
240.7
0.89
85
761
(3026361) Erythrocytes [#/volume] in Blood
632
6117
1.63
2.14
22.3
15.4
e12/l
4.6
4.6
0.16
619
5940
(3035941) MCH [Entitic mass]
632
6117
1.63
2.14
22.2
15.3
pg
30.1
30.1
0.09
627
6035
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
13
55
2.39
2.13
1.2
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
18
88
2.07
2.13
1.4
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
513
4804
1.29
2.09
4.1
3.6
mmol/l
5.9
5.8
0.46
479
4433
(3000963) Hemoglobin [Mass/volume] in Blood
632
6121
1.62
2.08
22.4
15.5
g/l
136.6
136.9
0.20
626
6037
(3010813) Leukocytes [#/volume] in Blood
632
6121
1.62
2.08
22.4
15.4
e9/l
7.0
6.7
3.61
619
5936
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
31
184
1.72
2.08
8.6
13.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
589
5628
1.40
2.07
13.4
9.8
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
15
4.03
2.04
3.0
2.3
umol/l
14.9
19.2
—
6
15
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
50
2.43
2.03
1.3
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
43
280
1.57
2.03
1.4
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
41
264
1.59
2.03
2.5
2.2
ug/l
7.2
8.7
0.24
34
239
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
50
338
1.52
2.01
1.1
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
13
57
2.31
1.98
1.2
1.2
—
—
—
0
0
(3013512) EKG study
140
1134
1.30
1.95
3.9
3.1
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
5
11
4.57
1.94
1.4
1.0
mg/g
10.9
5.2
—
5
11
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
11
4.57
1.94
1.0
1.2
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
11
4.57
1.94
1.4
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
16
3.77
1.94
1.0
1.1
—
—
—
0
0
(4027681)
9
33
2.75
1.93
1.2
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
13
58
2.27
1.92
1.2
1.1
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
86
651
1.37
1.91
3.0
2.2
s
29.6
29.7
0.06
86
635
(3027945) Reticulocytes/100 erythrocytes in Blood
58
410
1.45
1.89
4.9
2.9
%
1.6
1.7
0.15
51
370
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9
34
2.67
1.87
3.3
3.3
u/ml
669.8
618.5
—
9
34
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
29
175
1.69
1.86
1.6
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
17
3.55
1.84
1.2
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
28
168
1.70
1.83
1.8
1.6
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
49
338
1.49
1.81
1.4
1.5
iu/l
19.6
24.1
0.59
44
285
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
29
458
0.62
1.80
1.2
1.3
—
—
—
0
0
(3020891) Body temperature
23
131
1.78
1.79
7.3
4.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
584
5600
1.34
1.76
11.2
8.3
u/l
28.2
26.9
0.82
574
5425
(3006184) Hemoglobin [Mass/volume] in Capillary blood
16
81
2.00
1.76
1.4
2.5
g/l
137.3
130.4
—
8
67
(3006653) Thiamine [Moles/volume] in Blood
6
18
3.35
1.75
1.2
1.4
nmol/l
141.2
134.1
—
6
18
(3020682) Albumin/Creatinine [Ratio] in Urine
144
1188
1.27
1.74
3.6
4.2
mg/mmol
7.0
9.8
0.45
87
800
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
24
2.94
1.72
1.3
1.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
88
680
1.34
1.72
3.4
3.9
mmol/l
0.8
0.8
0.10
82
650
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
5
13
3.87
1.72
1.0
1.2
—
654.0
—
0
5
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
13
3.87
1.72
1.6
1.7
ug/l
7.3
8.6
—
5
13
(3023410) Appearance of Cerebral spinal fluid
11
48
2.31
1.71
1.7
1.6
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
12
55
2.20
1.68
1.1
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
272
2415
1.21
1.66
3.3
2.7
ug/l
100.2
94.9
0.23
253
2260
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
19
3.18
1.66
1.8
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
71
534
1.37
1.66
1.4
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
15
76
2.00
1.65
2.1
1.9
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
14
3.59
1.62
2.8
1.9
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
41
280
1.49
1.61
5.6
3.0
e9/l
68.1
69.6
0.08
29
200
(3033705) Calcium.ionized [Moles/volume] in Venous blood
11
50
2.22
1.57
1.9
2.2
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
8
33
2.44
1.54
3.3
2.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
37
250
1.51
1.53
2.5
1.6
—
—
—
0
0
(4211845)
5
15
3.35
1.52
2.8
1.9
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
56
413
1.39
1.49
2.0
2.5
g/l
0.2
0.2
0.84
51
391
(3017732) Neutrophils [#/volume] in Blood
45
319
1.44
1.48
2.9
2.8
e9/l
3.8
3.8
0.00
36
277
(1761482) Bacteria [#/volume] in Urine by Culture
19
110
1.75
1.44
4.8
4.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
22
2.74
1.43
1.2
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
191
2178
0.83
1.42
2.4
2.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
140
1180
1.24
1.41
1.6
1.4
g/l
2.0
2.2
0.43
86
736
(3045414) Leukocytes [Presence] in Urine
28
182
1.56
1.39
1.8
1.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
20
119
1.70
1.39
1.2
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
12
60
2.02
1.38
1.4
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
98
794
1.27
1.38
1.6
1.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
48
350
1.40
1.37
1.4
1.3
u/ml
207.3
174.0
0.21
43
318
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
41
2.21
1.37
1.2
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
469
4426
1.20
1.37
5.3
4.7
mmol/mol
39.0
38.8
0.18
446
4156
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
17
2.96
1.36
1.0
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
5
17
2.96
1.36
2.0
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
28
184
1.54
1.34
2.2
2.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
48
641
0.73
1.31
1.6
1.6
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
16
91
1.78
1.30
1.3
1.2
u/ml
4.0
4.2
—
7
42
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
8
34
2.37
1.29
1.1
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
34
2.37
1.29
1.1
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
18
2.79
1.28
1.2
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
18
2.79
1.28
1.2
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
18
2.79
1.28
1.2
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
18
2.79
1.28
1.2
1.3
—
—
—
0
0
(4268621)
12
62
1.95
1.28
2.4
2.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
14
77
1.84
1.26
1.6
1.5
e6/l
11396.3
17417.0
—
8
55
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
16
92
1.76
1.26
1.3
1.2
u/ml
1.7
5.0
—
6
39
(3019420) Tryptase [Mass/volume] in Serum or Plasma
6
25
2.41
1.24
4.0
1.4
ug/l
19.0
7.5
—
6
20
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
76
605
1.29
1.24
1.6
1.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
27
180
1.52
1.23
1.9
1.7
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
11
56
1.98
1.22
1.2
1.9
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
22
140
1.59
1.21
1.5
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
6
26
2.32
1.19
1.0
1.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
26
2.32
1.19
1.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
22
141
1.58
1.18
1.5
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
132
1127
1.21
1.18
2.2
2.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
25
166
1.53
1.16
1.8
1.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
14
80
1.77
1.13
2.4
1.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
15
88
1.72
1.12
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
22
144
1.55
1.10
1.5
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
120
1023
1.21
1.09
2.0
2.0
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
5
21
2.39
1.09
2.0
1.5
u/l
17.6
16.3
—
5
21
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
5
21
2.39
1.09
2.0
1.2
u/l
8.4
9.0
—
5
21
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
21
2.39
1.09
1.2
1.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
21
2.39
1.09
1.4
1.0
iu/ml
165.4
221.5
—
5
21
(3027231) Wheat IgE Ab [Units/volume] in Serum
5
21
2.39
1.09
1.2
1.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
46
350
1.34
1.06
3.1
4.4
%
0.3
0.2
0.22
11
92
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
12
67
1.81
1.05
1.2
1.7
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
45
343
1.33
1.03
3.2
4.2
%
0.7
0.5
—
10
75
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
47
1.93
1.02
3.1
2.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
14
83
1.70
1.02
1.6
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
52
406
1.30
1.01
1.2
1.3
iu/ml
53.0
151.9
4.55
25
170
(3017181) Myelocytes/100 leukocytes in Blood
48
371
1.32
1.00
3.1
4.3
%
0.8
1.0
0.27
12
103
(3012441) Differential panel - Pleural fluid
7
35
2.01
1.00
2.1
1.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
23
2.18
0.98
1.0
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
23
2.18
0.98
1.0
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
23
2.18
0.98
1.0
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
23
2.18
0.98
1.0
1.9
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
16
100
1.61
0.97
4.9
3.6
u/ml
0.4
0.4
0.41
11
50
(4198724)
7
36
1.95
0.97
4.9
2.3
—
—
—
0
0
(4062490)
9
51
1.77
0.95
1.1
1.3
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
15
93
1.63
0.94
1.1
1.1
u/ml
1.1
2.7
—
9
48
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
17
109
1.57
0.94
3.2
5.2
—
549.0
—
0
12
(3024139) IgG subclass 3 [Mass/volume] in Serum
9
52
1.74
0.92
1.1
1.3
g/l
0.4
0.3
—
9
36
(3027135) IgG subclass 1 [Mass/volume] in Serum
9
52
1.74
0.92
1.1
1.3
g/l
6.1
6.4
—
9
36
(3028192) IgG subclass 2 [Mass/volume] in Serum
9
52
1.74
0.92
1.1
1.3
g/l
2.7
2.5
—
9
36
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
11
183
0.59
0.92
1.3
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
13
78
1.68
0.92
8.2
3.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
28
2.15
0.91
1.3
1.2
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
6
28
2.15
0.91
1.8
2.5
e9/l
0.1
0.1
—
6
28
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
45
351
1.30
0.90
3.4
5.1
ug/l
2.5
19.1
0.72
33
278
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
16
241
0.66
0.89
1.2
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
70
578
1.24
0.89
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
42
1.92
0.88
1.4
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
42
1.92
0.88
1.4
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
42
1.92
0.88
1.4
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
17
111
1.55
0.88
1.7
2.9
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
63
515
1.25
0.87
3.1
3.2
umol/l
4.8
6.9
1.56
55
446
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
43
1.87
0.87
1.4
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
43
1.87
0.87
1.4
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
43
1.87
0.87
1.4
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
30
2.01
0.87
1.2
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
8
44
1.83
0.86
1.0
1.8
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
80
1.64
0.85
1.2
1.6
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
31
1.94
0.84
1.2
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
31
1.94
0.84
1.2
1.1
miu/ml
1647.5
1490.4
—
6
31
(3041806) Other cells [#/volume] in Blood by Manual count
8
45
1.79
0.84
2.1
1.6
—
—
—
0
0
(3000492) Spirometry study
63
518
1.24
0.84
1.4
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
167
1501
1.15
0.82
2.0
2.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
12
73
1.66
0.82
1.2
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
14
89
1.59
0.81
1.3
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
64
768
0.82
0.81
1.3
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
25
181
1.40
0.81
1.6
4.3
g/l
0.3
0.3
—
7
88
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
8
47
1.71
0.81
1.1
1.4
pmol/l
289.4
344.6
—
8
38
(3052851) Hemolysis interference index of Serum or Plasma
18
122
1.49
0.81
2.0
3.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
10
58
1.74
0.80
1.3
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
42
331
1.29
0.79
3.4
2.4
ml/min/173m2
76.6
72.2
0.31
19
134
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
1.4
—
12.4
—
0
8
(4094501)
15
98
1.54
0.79
1.0
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
520
5037
1.15
0.76
4.1
3.7
mmol/l
4.7
4.7
0.03
492
4747
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
9
53
1.71
0.75
1.3
1.2
—
—
—
0
0
(3036489) Thrombin time
27
201
1.36
0.75
3.5
2.6
s
24.6
21.1
0.72
22
177
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
40
316
1.28
0.75
3.6
3.6
pmol/l
4.2
4.7
2.84
35
282
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
20
141
1.43
0.75
2.2
2.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
32
245
1.32
0.75
1.7
1.3
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
5
24
2.09
0.74
1.4
1.0
u/ml
45.6
29.4
—
5
24
(3035933) Granulocytes/100 leukocytes in Blood
5
24
2.09
0.74
1.0
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
25
2.01
0.73
1.8
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
7
39
1.80
0.72
1.1
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
156
1409
1.14
0.72
3.2
2.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
10
60
1.68
0.72
1.0
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
102
893
1.17
0.72
1.7
1.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
40
1.76
0.71
1.6
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
7
40
1.76
0.71
1.1
1.4
u/ml
—
0.1
—
0
13
(3037756) Immunofixation for Serum or Plasma
9
58
1.56
0.70
1.3
1.9
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
14
93
1.52
0.70
4.9
3.0
e9/l
3.9
3.9
0.00
14
93
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
42
1.67
0.68
1.0
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
42
1.67
0.68
1.0
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
42
1.67
0.68
1.0
1.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
18
127
1.43
0.68
1.4
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
516
5010
1.13
0.67
4.0
3.6
mmol/l
1.4
1.5
3.21
486
4699
(3050129) First trimester maternal screen panel - Serum or Plasma
26
338
0.76
0.66
1.4
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
132
1187
1.14
0.66
1.8
1.7
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
7
44
1.60
0.65
1.9
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
29
1.73
0.64
2.4
1.2
—
—
—
0
0
(1002224) Polysomnography panel
33
261
1.28
0.63
1.1
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
30
1.67
0.61
3.2
2.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
50
1.61
0.61
1.0
1.8
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
51
1.58
0.60
1.4
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
20
0.00
0.60
0.0
2.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
523
5093
1.12
0.60
4.4
4.0
mmol/l
2.8
2.8
0.02
490
4768
(3026389) Candida sp identified in Specimen by Organism specific culture
8
52
1.54
0.59
1.3
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
124
1119
1.13
0.59
3.6
3.8
ug/l
1.5
2.2
1.09
114
1015
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
14
97
1.45
0.59
4.9
3.2
%
56.9
56.1
0.08
14
97
(3025159) Blasts/100 leukocytes in Blood
41
337
1.23
0.59
3.2
4.5
%
0.0
0.1
—
9
79
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
497
4829
1.11
0.58
3.7
3.3
mmol/l
1.4
1.3
2.56
472
4527
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
60
513
1.19
0.58
4.3
3.4
%
31.5
31.9
0.11
44
356
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
21
275
0.76
0.58
1.9
1.8
—
—
—
0
0
(3011648) Oxygen content in Venous blood
6
35
1.72
0.58
7.2
3.9
%
12.8
11.7
—
6
35
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
12
81
1.49
0.57
1.6
1.2
—
—
—
0
0
(4306422)
12
81
1.49
0.57
1.1
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
12
81
1.49
0.57
1.6
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
21
274
0.76
0.57
2.0
1.8
mg/l
3.3
2.9
0.22
14
185
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
26
203
1.29
0.56
1.4
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
8
55
1.46
0.56
1.3
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
55
1.46
0.56
1.1
2.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
8
55
1.46
0.56
1.3
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
41
492
0.82
0.56
1.5
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
18
133
1.36
0.55
1.2
1.3
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
6
39
1.54
0.53
1.3
2.0
e9/l
0.3
0.2
—
6
32
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
40
1.50
0.51
12.2
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
16
118
1.36
0.50
1.4
1.7
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
6
41
1.47
0.50
1.0
1.2
—
72.2
—
0
5
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
6
41
1.47
0.50
1.3
1.9
e6/l
328.3
487.5
—
6
32
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
41
1.47
0.50
1.8
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
45
1.56
0.49
1.0
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
13
93
1.41
0.48
1.4
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
177
1651
1.10
0.48
1.6
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
202
1896
1.09
0.48
2.2
2.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
75
666
1.14
0.47
2.0
1.9
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
83
0.60
0.46
8.6
2.9
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
14
103
1.37
0.45
1.1
1.1
u/ml
1.7
6.5
—
7
38
(3005988) Vibrio sp identified in Specimen by Organism specific culture
8
56
1.43
0.42
1.3
1.4
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
12
87
1.39
0.42
1.1
1.0
u/ml
0.1
0.8
—
5
25
(3034860) Kappa light chains.free [Mass/volume] in Serum
12
87
1.39
0.42
3.8
3.3
mg/l
18.6
112.8
0.65
12
65
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
12
87
1.39
0.42
3.8
3.3
mg/l
42.2
25.6
0.29
12
66
(44813793)
5
32
1.57
0.42
1.4
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
8
57
1.41
0.42
1.3
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
8
57
1.41
0.42
1.3
1.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.3
—
—
—
0
0
(4035726)
42
362
1.17
0.40
1.3
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
28
232
1.22
0.40
5.3
4.8
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
34
1.47
0.40
2.2
2.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
102
0.68
0.40
1.1
1.3
—
—
—
0
0
(44790048)
8
61
1.32
0.39
1.4
1.5
—
—
—
0
0
(44790047)
8
61
1.32
0.39
1.4
1.5
—
—
—
0
0
(44790049)
8
61
1.32
0.39
1.4
1.5
—
—
—
0
0
(44806118)
8
61
1.32
0.39
1.4
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
5
35
1.43
0.39
1.4
1.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
11
80
1.38
0.38
1.4
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
36
1.39
0.38
1.2
1.2
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
12
89
1.35
0.38
2.7
4.1
—
2867.0
—
0
9
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
48
421
1.15
0.38
2.7
2.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
10
72
1.39
0.37
4.0
3.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
17
212
0.80
0.36
1.3
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
98
903
1.10
0.35
3.5
3.3
%
19.0
21.3
0.71
31
355
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
43
1.40
0.35
1.0
1.0
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
20
163
1.23
0.34
7.0
3.1
%
160.3
180.7
0.49
20
157
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
12
91
1.32
0.34
1.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
23
191
1.21
0.34
1.6
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
46
1.31
0.33
2.8
3.9
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
35
304
1.16
0.32
1.5
1.6
mu/l
290.0
292.6
0.02
30
273
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
18
146
1.24
0.32
1.5
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
101
1.29
0.32
1.1
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
24
283
0.84
0.31
1.7
1.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
54
1.30
0.30
1.1
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
15
120
1.26
0.30
1.5
1.7
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
12
93
1.30
0.30
1.2
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
46
411
1.13
0.30
2.0
2.1
nmol/l
11.7
13.0
0.57
40
379
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
7
56
1.25
0.29
1.9
1.5
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
17
206
0.82
0.29
1.8
1.7
nmol/l
39.0
37.0
0.15
17
199
(3002385) Erythrocyte distribution width [Ratio]
476
4674
1.06
0.29
18.5
13.1
%
13.5
13.5
0.31
470
4595
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
57
1.23
0.29
1.3
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
39
346
1.14
0.28
1.9
2.2
u/l
7221.4
3929.5
0.25
12
152
(3048929) Epstein Barr virus Ab [Presence] in Serum
30
261
1.16
0.28
1.4
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
8
67
1.20
0.26
1.1
1.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
77
1.30
0.26
1.7
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
23
267
0.86
0.26
1.6
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
23
267
0.86
0.26
1.6
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
23
267
0.86
0.26
1.6
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
23
266
0.86
0.25
1.6
1.4
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
14
114
1.23
0.25
1.1
1.3
ug/l
2.9
3.0
0.04
14
103
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
12
96
1.25
0.24
1.9
2.4
ug/min
270.7
138.3
—
7
59
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
78
1.29
0.24
1.4
1.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
15
124
1.21
0.24
1.7
1.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
38
1.32
0.23
1.4
1.9
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
38
1.32
0.23
1.0
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
39
1.28
0.23
1.4
1.3
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
5
40
1.25
0.22
1.4
2.2
—
2.8
—
0
19
(3013139) Helicobacter pylori Ag [Presence] in Stool
32
286
1.12
0.22
1.1
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
32
286
1.12
0.22
5.5
4.7
mmol/l
-0.4
1.8
3.04
27
217
(3044007) Cell count panel - Peritoneal fluid
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(44806420)
0
11
0.00
0.21
0.0
3.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3010421) pH of Blood
8
102
0.78
0.21
5.8
3.0
ph
7.4
7.4
—
8
81
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
12
0.00
0.21
0.0
4.8
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
13
0.00
0.21
0.0
2.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
6
49
1.23
0.20
1.7
2.2
—
38.4
—
0
5
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
53
1.13
0.18
1.0
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
27
242
1.12
0.18
1.7
2.2
u/ml
23.1
37.1
0.65
27
232
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
60
1.17
0.18
1.1
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
526
5207
1.05
0.17
16.5
11.3
%
39.8
40.6
1.14
411
4205
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
18
157
1.15
0.17
1.2
1.2
u/ml
0.2
2.5
1.53
11
75
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
63
1.11
0.17
1.0
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
35
381
0.91
0.16
1.5
1.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
14
120
1.17
0.16
1.8
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
38
351
1.09
0.16
1.5
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
13
111
1.17
0.16
1.8
2.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
19
168
1.13
0.16
1.2
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
6
78
0.77
0.15
5.7
3.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
46
429
1.08
0.15
3.7
3.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
125
1205
1.05
0.15
1.6
1.7
mmol/l
1.4
1.4
0.09
109
1035
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
82
1.10
0.15
1.0
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
13
112
1.16
0.14
1.5
3.3
umol/l
2.6
9.7
—
5
87
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
15
132
1.14
0.13
1.9
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
16
142
1.13
0.12
1.2
1.1
u/ml
0.6
4.0
—
6
35
(3021879) Hepatitis B virus core Ab [Presence] in Serum
53
506
1.05
0.10
1.4
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
44
1.14
0.10
1.4
1.3
—
—
—
0
0
(4024509)
5
44
1.14
0.10
1.4
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
56
536
1.05
0.10
2.0
1.8
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
18
164
1.10
0.10
4.0
3.0
g/l
3.4
3.7
0.23
18
154
(3003888) Timothy IgE Ab [Units/volume] in Serum
16
145
1.11
0.09
1.2
1.1
u/ml
11.0
6.0
—
9
90
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
80
826
0.96
0.09
1.5
1.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
34
322
1.06
0.08
4.4
3.5
mmol/l
1.2
1.2
0.42
29
283
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
65
1.08
0.08
1.1
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
71
0.84
0.07
1.7
1.6
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
7
80
0.87
0.07
1.1
1.1
g/l
1.2
1.4
—
7
72
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
9
88
1.02
0.07
1.4
1.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
90
0.89
0.07
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
12
132
0.91
0.06
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
12
132
0.91
0.06
1.1
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
15
138
1.09
0.06
1.2
1.1
u/ml
0.6
2.1
—
9
75
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
99
1.11
0.06
1.4
1.9
g/l
2.6
2.9
—
6
81
(3015235) Bicarbonate [Moles/volume] in Capillary blood
9
103
0.87
0.06
2.6
3.1
mmol/l
24.2
25.2
—
9
87
(3004588) Protein electrophoresis panel - Serum or Plasma
22
207
1.06
0.06
3.4
2.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
20
213
0.94
0.06
1.6
1.4
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
59
573
1.03
0.06
8.2
6.6
mmol/l
1.0
1.1
0.33
54
537
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
66
676
0.97
0.05
2.3
2.4
ug/l
0.5
0.8
2.68
35
375
(40768793) Breast Pathology biopsy report
12
111
1.08
0.04
1.3
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
19
199
0.95
0.03
2.1
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
13
122
1.07
0.02
1.8
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
96
951
1.01
0.01
1.4
1.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
105
1.05
0.00
1.4
1.9
g/l
3.2
3.6
—
6
78
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
105
1.05
0.00
1.4
1.9
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
12
116
1.04
0.00
1.3
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
10
103
0.97
0.00
1.4
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
26
256
1.02
0.00
1.2
1.3
miu/ml
272.1
266.4
0.03
16
123
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
15
147
1.02
0.00
1.3
1.9
iu/l
2.4
6.3
—
6
52
(3000494) Fungus identified in Specimen by Culture
53
525
1.01
0.00
1.2
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
21
212
0.99
0.00
1.6
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
22
218
1.01
0.00
1.6
1.5
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
66
0.91
0.00
1.7
1.5
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
7.6
—
0.4
—
0
8
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
4.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
9
91
0.99
0.00
1.4
1.3
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
22.2
—
0
5
(3007463) Buprenorphine [Presence] in Urine
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
83
0.96
0.00
1.0
1.3
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
5
0.00
0.00
0.0
7.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
5
57
0.88
0.00
1.2
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
5
54
0.93
0.00
1.2
1.9
mosm/kgh2o
277.4
287.4
—
5
43
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
98
0.92
0.00
1.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
6
0.00
0.00
0.0
8.3
—
—
—
0
0
(3033882) Carnitine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
31.0
—
0
5
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
114.2
—
0
5
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
87
0.92
0.00
2.0
2.6
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.9
—
55.5
—
0
7
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
49
1.02
0.00
1.8
2.8
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
59
0.85
0.00
1.0
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
7.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
6
68
0.88
0.00
2.5
2.9
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
1.9
—
0
5
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_TORTICOLLIS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_TORTICOLLIS | 1.139 [0.93, 1.4] | 0.219 |
| Birth year | 0.997 [0.99, 1.01] | 0.44 |
During the follow-up period (1.1.1998 — 31.12.2019), 127 out of 2594 females with M13_TORTICOLLIS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_TORTICOLLIS | 1.233 [1.0, 1.51] | 0.045 |
| Birth year | 0.983 [0.97, 0.99] | 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 149 out of 3021 males with M13_TORTICOLLIS died.
Mortality risk
Mortality risk for people of age
years, who have M13_TORTICOLLIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.114% | 0.207% |
| 5 | 0.744% | 1.233% |
| 10 | 1.772% | 3.16% |
| 15 | 3.443% | 5.849% |
| 20 | 6.289% | 9.76% |
Relationships between endpoints
↥Index endpoint: M13_TORTICOLLIS – Torticollis
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data